Funding for this research was provided by:
Merck Sharp and Dohme
Received: 12 February 2020
Accepted: 23 October 2020
First Online: 3 November 2020
Ethics approval and consent to participate
: Written informed consent will be obtained from all participants. The study protocol was approved by the Ethical Review Boards of the University of Fukui Hospital. This trial is registered in the Japan Registry of Clinical Trials (jRCTs051190039) and on ExternalRef removed (NCT04022148).
: Not applicable.
: Tetsuji Kurokawa received lecture fees from MSD. All other authors declare no conflicts of interest.